Skip to content

Medical emergency? What to do

Sepsis campaign improving treatment of major killer

3-RXPublished January 14, 20104 min read

Key points

  • "A multifaceted performance improvement initiative was successful in changing treatment behavior as evidenced by a significant increase in compliance with sepsis performance measures," says lead author Mitchell M.
  • With the goal of improving sepsis outcomes through standardized care, the Society of Critical Care Medicine, European Society of Intensive Care Medicine, and the International Sepsis Forum launched the Surviving Sepsis Campaign in 2002.
  • The study reports on 15,022 patients with severe sepsis or in septic shock from ICUs, emergency departments and wards representing 165 hospitals in 30 countries.
  • They also remain major killers in the developing world."

A reduction in hospital mortality from severe sepsis and septic shock was associated with participation in the Surviving Sepsis Campaign performance improvement initiative, according to an article published simultaneously in the February issues of Critical Care Medicine and Intensive Care Medicine and posted ahead of print at www.ccmjournal.com.

"A multifaceted performance improvement initiative was successful in changing treatment behavior as evidenced by a significant increase in compliance with sepsis performance measures," says lead author Mitchell M. Levy, M.D. "These results should encourage similar efforts with other evidence-based guidelines as a means of improving patient care and outcomes."

"Application of two time-related bundles of care based on the Surviving Sepsis Campaign guidelines in a performance improvement program results in measurable behavior change in the care of patients with severe sepsis and septic shock," adds Dr. Levy, a professor of medicine at Brown University School of Medicine in Providence, R.I. A "bundle" is a group of therapeutic actions, which applied together and measured for compliance, improve outcomes as compared to being applied individually.

With the goal of improving sepsis outcomes through standardized care, the Society of Critical Care Medicine, European Society of Intensive Care Medicine, and the International Sepsis Forum launched the Surviving Sepsis Campaign in 2002. The Campaign's updated 2008 guidelines are endorsed by 18 professional societies and hospital networks globally.

Applying the Campaign guidelines was associated with sustained, continuous quality improvement in sepsis care. Additionally, a decline in hospital mortality rates was associated with participation in the Campaign.

The study reports on 15,022 patients with severe sepsis or in septic shock from ICUs, emergency departments and wards representing 165 hospitals in 30 countries. According to the investigators, this is the largest prospective series of severe sepsis patients yet to be studied.

They found the unadjusted hospital mortality rate decreased from 37% to 30.8% over two years. The adjusted odds ratio for mortality improved the longer a site participated in the Campaign resulting in an adjusted drop of 0.8% per quarter and 5.4% over two years.

In an accompanying editorial, Simon Finfer, MD, of The George Institute for International Health and University of Sydney, Australia, says: "It is clear that severe sepsis and septic shock remain major public health issues that are likely to result in increasing morbidity and mortality due to ageing of the population of developed countries. They also remain major killers in the developing world."

###

Resources to implement the campaign are available at www.survivingsepsis.org for ICU and ED practitioners who wish to implement it.

Critical Care Medicine is the official journal of the Society of Critical Care Medicine. It is the premier peer-reviewed, scientific publication in critical care medicine. Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research, and advances in equipment and techniques.

Editor's note: The Surviving Sepsis Campaign was supported by Eli Lilly and Co., Edwards Lifescience. Philips Medical Systems, the Society of Critical Care Medicine, and European Society of Intensive Care Medicine.

Editor's note: Mitchell M. Levy, MD, has received grants from Eli Lilly & Co and Philips Medical Systems. Please refer to the article for additional information on funding and support of coauthors.

Editor's note: Simon Finfer, MD, has received travel support from CSL Ltd, Fresenius Kabi Deutschland and Cardinal Health and research funding from CSL Ltd, and Fresenius Kabi Deutschland. The George Institute for International Health has received reimbursement from Eli Lilly and Eisai for Dr. Finfer serving on the steering committees of clinical trials.

Amy Jenkins (January 12-13)
amy@jenkinspr
312-371-8365

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Public Health

Parasitic DNA proliferates in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.